Gene · 2693
Papers3,015
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,015
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| State-Specific Peptide Design Targeting G Protein-Coupled Receptors. | J Chem Inf Model | 2025 | 41074841 | PubTator, text mining | PubMed |
| Ghrelin-GHSR-LEAP2 system in the pathophysiology of type 2 diabetes. | iScience | 2025 | 41069857 | PubTator, text mining | PubMed |
| MRAP2 potentiates GPCR signaling by conserved mechanisms that are disrupted by obesity-associated genetic variants. | bioRxiv | 2025 | 41040264 | PubTator, text mining | PubMed |
| MRAP2 modifies the signaling and oligomerization state of the melanocortin-4 receptor. | Nat Commun | 2025 | 40998819 | PubTator, text mining | PubMed |
| An interoceptive model of energy allostasis linking metabolic and mental health. | Sci Adv | 2025 | 40991698 | PubTator, text mining | PubMed |
| The role of intrinsically disordered domains in regulating G protein coupled receptor signaling. | bioRxiv | 2025 | 40964316 | PubTator, text mining | PubMed |
| Ghrelin's potential as a therapeutic target for chronic inflammatory diseases: evidence from human endometrial stromal cells. | Front Endocrinol (Lausanne) | 2025 | 40958911 | PubTator, text mining | PubMed |
| Differential effects of sodium on agonist-induced conformational transitions and signaling at μ and κ opioid receptors. | bioRxiv | 2025 | 40950006 | PubTator, text mining | PubMed |
| Molecular Insights into Bromocriptine Binding to GPCRs Within Histamine-Linked Signaling Networks: Network Pharmacology, Pharmacophore Modeling, and Molecular Dynamics Simulation. | Int J Mol Sci | 2025 | 40943635 | PubTator, text mining | PubMed |
| Selective Coupling of Aminophosphole-Based Fluorophores to Unprotected Peptides through P-S Bond Formation. | Bioconjug Chem | 2025 | 40928481 | PubTator, text mining | PubMed |
| ACtriplet: An improved deep learning model for activity cliffs prediction by in tegrating triplet loss and pre-training. | J Pharm Anal | 2025 | 40893440 | PubTator, text mining | PubMed |
| Ghrelin and LEAP2: Their Interaction Effect on Appetite Regulation and the Alterations in Their Levels Following Bariatric Surgery. | Medicina (Kaunas) | 2025 | 40870497 | PubTator, text mining | PubMed |
| Immunosenescence and the Geriatric Giants: Molecular Insights into Aging and Healthspan. | Med Sci (Basel) | 2025 | 40843723 | PubTator, text mining | PubMed |
| Lower ghrelin in depression might be connected to the absence of psychotic-like experiences. | Endocr Connect | 2025 | 40823927 | PubTator, text mining | PubMed |
| Effects of Sarcopenia on the Outcomes and Safety of Chemoradiotherapy Followed by Durvalumab for the Treatment of Patients With Locally Advanced Non-Small Cell Lung Cancer. | Thorac Cancer | 2025 | 40814291 | PubTator, text mining | PubMed |
| PIT-1/SF-1-positive pituitary tumors in patients with acromegaly: transcriptomic perspective. | Acta Neuropathol Commun | 2025 | 40813692 | PubTator, text mining | PubMed |
| Increased protein intake in healthy males exposed to an appetite modulating, whey-derived peptide hydrolysate. | Food Funct | 2025 | 40704765 | PubTator, text mining | PubMed |
| Real-world effectiveness of anamorelin in patients with unresectable and relapse pancreatic cancer: a prospective observational study. | J Gastrointest Oncol | 2025 | 40672072 | PubTator, text mining | PubMed |
| Determination of Biotin Interference in Pediatric Obesity Related ELISA Research Kits Biotin Interference in Manual ELISA Kits. | J Clin Lab Anal | 2025 | 40657850 | PubTator, text mining | PubMed |
| Effect of anamorelin on body weight in patients with gastric cancer-associated cachexia: an observational study. | Gastric Cancer | 2025 | 40627291 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2693/papers?page=4